Skip to main content
. 2016 Aug 2;11(8):e0160485. doi: 10.1371/journal.pone.0160485

Fig 5. Meta-analysis of the overall response rate in the PD-1 antibody monotherapy groups and the other treatment groups.

Fig 5

PD-1 antibody treatment was associated with a higher overall response rate.